Adverts

Open Access Articles- Top Results for Nemonapride

Nemonapride

</th></tr>
Nemonapride
File:Nemonapride.png
Systematic (IUPAC) name
N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide
Clinical data
AHFS/Drugs.com International Drug Names
  • (Prescription only)
Oral
Identifiers
75272-39-8
None
PubChem CID 4452
UNII Q88T5P3444 7pxY
KEGG D01468 7pxY
Chemical data
Formula C21H26ClN3O2
387.90 g/mol
 14pxY (what is this?)  (verify)

Nemonapride (Emilace) is an atypical antipsychotic approved in Japan for the treatment of schizophrenia. It was launched by Yamanouchi in 1991. Nemonapride acts as a D2 and D3 receptor antagonist, and is also a potent 5-HT1A receptor agonist. It has affinity for sigma receptors.

See also

References



Lua error in package.lua at line 80: module 'Module:Buffer' not found.